Literature DB >> 2098004

Emergence of antibiotic-resistant bacteria during selective decontamination of the digestive tract.

R Nau, R Rüchel, H Mergerian, U Wegener, T Winkelmann, H W Prange.   

Abstract

Mesh：

Substances：

Year:  1990        PMID： 2098004     DOI： 10.1093/jac/25.5.881

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  10 in total

1.  Emergence of resistance during selective decontamination of the digestive tract.

Authors:  F Daschner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-01       Impact factor: 3.267

2.  Cost effectiveness of selective decontamination of the digestive tract in liver transplant patients.

Authors:  P J van Enckevort; J H Zwaveling; J T Bottema; J K Maring; I J Klompmaker; M J Slooff; E M TenVergert
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 3.  Selective decontamination of the digestive tract: indications and problems.

Authors:  H Lode; T Schaberg; R Stahlmann
Journal:  Infection       Date:  1995 May-Jun       Impact factor: 3.553

Review 4.  Prevention of hospital-acquired pneumonia in critically ill patients.

Authors:  D H Hamer; M Barza
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

Review 5.  [Diagnosis and therapy of sepsis].

Authors:  K Reinhart; F M Brunkhorst; H-G Bone; H Gerlach; M Gründling; G Kreymann; P Kujath; G Marggraf; K Mayer; A Meier-Hellmann; C Peckelsen; C Putensen; F Stüber; M Quintel; M Ragaller; R Rossaint; N Weiler; T Welte; K Werdan
Journal:  Clin Res Cardiol       Date:  2006-08       Impact factor: 5.460

Review 6.  Critical care pharmacotherapy. A review.

Authors:  M Tryba; P J Kulka
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

7.  Mupirocin/chlorexidine to prevent methicillin-resistant Staphylococcus aureus infections: post hoc analysis of a placebo-controlled, randomized trial using mupirocin/chlorhexidine and polymyxin/tobramycin for the prevention of acquired infections in intubated patients.

Authors:  C Camus; V Sebille; A Legras; B Garo; A Renault; P Le Corre; P-Y Donnio; A Gacouin; D Perrotin; Y Le Tulzo; E Bellissant
Journal:  Infection       Date:  2014-01-25       Impact factor: 3.553

Review 8.  [Diagnosis and therapy of sepsis. Guidelines of the German Sepsis Society Inc. and the German Interdisciplinary Society for Intensive and Emergency Medicine].

Authors:  K Reinhart; F Brunkhorst; H Bone; H Gerlach; M Gründling; G Kreymann; P Kujath; G Marggraf; K Mayer; A Meier-Hellmann; C Peckelsen; C Putensen; M Quintel; M Ragaller; R Rossaint; F Stüber; N Weiler; T Welte; K Werdan
Journal:  Internist (Berl)       Date:  2006-04       Impact factor: 0.743

9.  The effect of selective decontamination of the digestive tract on gastrointestinal enterococcal colonization in ITU patients.

Authors:  H Humphreys; R Winter; A Pick
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

Review 10.  Prophylactic use of the new quinolones for prevention of nosocomial infection in the intensive care unit.

Authors:  P D Potgieter; J M Hammond
Journal:  Drugs       Date:  1995       Impact factor: 9.546
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.